We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RAPT icon
201
DELISTED
RAPT Therapeutics
RAPT
$1.54M 0.05%
7,736
-3,991
-34% -$494K
2022 Q2
6 quarters
DASH icon
202
DoorDash
DASH
$85.1B
$1.48M 0.05%
+15,000
New +$1.33M
2023 Q4
0 quarters
OCUL icon
203
Ocular Therapeutix
OCUL
$1.66B
$1.48M 0.05%
332,091
-10,020
-3% -$29.6K
2022 Q1
7 quarters
MIRM icon
204
Mirum Pharmaceuticals
MIRM
$5.58B
$1.47M 0.05%
49,912
-11,088
-18% -$336K
2023 Q2
2 quarters
RLAY icon
205
Relay Therapeutics
RLAY
$3.92B
$1.47M 0.05%
133,733
-13,113
-9% -$111K
2022 Q4
4 quarters
XFOR icon
206
X4 Pharmaceuticals
XFOR
$289M
$1.46M 0.05%
58,101
+6,101
+12% +$148K
2023 Q2
2 quarters
MTCH icon
207
Match Group
MTCH
$9.43B
$1.46M 0.05%
40,000
-10,000
-20% -$338K
2023 Q1
3 quarters
LRMR icon
208
Larimar Therapeutics
LRMR
$277M
$1.46M 0.05%
319,901
-58,604
-15% -$198K
2022 Q4
4 quarters
IONS icon
209
Ionis Pharmaceuticals
IONS
$7.52B
$1.45M 0.05%
28,624
-33,435
-54% -$1.6M
2022 Q1
7 quarters
MGM icon
210
MGM Resorts International
MGM
$7.36B
$1.44M 0.05%
32,241
-17,259
-35% -$677K
2023 Q1
3 quarters
PEN icon
211
Penumbra
PEN
$12.6B
$1.42M 0.04%
5,648
+4,279
+313% +$946K
2022 Q1
7 quarters
ZYME icon
212
Zymeworks
ZYME
$1.85B
$1.42M 0.04%
136,313
-208,159
-60% -$1.66M
2022 Q2
6 quarters
WEL icon
213
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.4M 0.04%
125,054
-56,209
-31% -$622K
2022 Q1
7 quarters
ATEC icon
214
Alphatec Holdings
ATEC
$1.65B
$1.4M 0.04%
+92,821
New +$1.11M
2023 Q4
0 quarters
ROK icon
215
Rockwell Automation
ROK
$48B
$1.4M 0.04%
+4,500
New +$1.26M
2023 Q4
0 quarters
HCMA icon
216
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.4M 0.04%
125,054
-56,209
-31% -$624K
2022 Q1
7 quarters
WELL icon
217
Welltower
WELL
$162B
$1.36M 0.04%
15,117
-53,366
-78% -$4.63M
2022 Q3
5 quarters
AGEN icon
218
Agenus
AGEN
$346M
$1.35M 0.04%
81,420
+9,216
+13% +$153K
2022 Q1
7 quarters
PHM icon
219
Pultegroup
PHM
$21.4B
$1.33M 0.04%
+12,918
New +$1.1M
2023 Q4
0 quarters
BCYC icon
220
Bicycle Therapeutics
BCYC
$272M
$1.33M 0.04%
73,601
-4,301
-6% -$71.2K
2022 Q1
7 quarters
KIDS icon
221
OrthoPediatrics
KIDS
$565M
$1.31M 0.04%
40,314
-15,905
-28% -$461K
2022 Q1
7 quarters
NFYS icon
222
DELISTED
Enphys Acquisition Corp.
NFYS
$1.31M 0.04%
122,826
-55,207
-31% -$585K
2022 Q2
6 quarters
RIGL icon
223
Rigel Pharmaceuticals
RIGL
$917M
$1.3M 0.04%
89,934
-25,243
-22% -$258K
2022 Q1
7 quarters
MRSN icon
224
DELISTED
Mersana Therapeutics
MRSN
$1.29M 0.04%
22,226
+10,369
+87% +$417K
2023 Q3
1 quarter
ARDX icon
225
Ardelyx
ARDX
$847M
$1.27M 0.04%
204,600
-15,400
-7% -$69.1K
2023 Q3
1 quarter
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.